Journal of shoulder and elbow surgery · 2025
Preoperative testosterone replacement therapy is associated with increased rates of periprosthetic joint infection, acute kidney injury, and emergency department utilization after total shoulder arthroplasty: a propensity-score matched analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
White Alexander E, Omurzakov Argen, Omurzakov Arsen M, Athanasian Christian E, Brusalis Christopher M, Kew Michelle E, Fu Michael C, Gulotta Lawrence V, Taylor Samuel A
Аннотация
BACKGROUND: The use of testosterone replacement therapy (TRT) has increased in recent years; however, its effect on surgical outcomes and long-term implant survival in total shoulder arthroplasty (TSA) remains unclear. This study aimed to assess the association between preoperative TRT and postoperative complications following TSA.
METHODS: The TriNetX database was queried to identify patients undergoing TSA before 2020. Patients were then stratified based on preoperative TRT within 1 year before surgery. Propensity score matching was performed in a 1:1 ratio to balance demographic variables and comorbidities. Outcomes assessed included 90-day and 1-year medical and implant complications and 5-year implant complications. Statistical analyses were performed using TriNetX's built-in analytics platform.
RESULTS: Following propensity score matching, 1,369 patients were included in each cohort and no baseline differences were detected. At 90 days postoperatively, TRT patients had significantly higher rates of emergency department (ED) visits (13.7% vs. 8.1%, risk ratio [RR]: 1.69, P < .001). At 1 year, TRT patients demonstrated increased rates of ED utilization (26.6% vs. 16.9%, RR: 1.58, P < .001), acute kidney injury (17.5% vs. 12.1%, RR: 1.45, P < .001), and periprosthetic joint infection (PJI) (4.8% vs. 2.4%, RR: 2.00, P < .001). At 5 years, TRT was associated with increased rates of PJI (7.9% vs. 4.5%, RR: 1.74, P < .001).
CONCLUSIONS: Preoperative TRT is associated with an increased risk of PJI, acute kidney injury, and postoperative ED visits following TSA. These findings highlight the need for careful preoperative risk assessment and patient counseling when considering TSA in patients on TRT.
METHODS: The TriNetX database was queried to identify patients undergoing TSA before 2020. Patients were then stratified based on preoperative TRT within 1 year before surgery. Propensity score matching was performed in a 1:1 ratio to balance demographic variables and comorbidities. Outcomes assessed included 90-day and 1-year medical and implant complications and 5-year implant complications. Statistical analyses were performed using TriNetX's built-in analytics platform.
RESULTS: Following propensity score matching, 1,369 patients were included in each cohort and no baseline differences were detected. At 90 days postoperatively, TRT patients had significantly higher rates of emergency department (ED) visits (13.7% vs. 8.1%, risk ratio [RR]: 1.69, P < .001). At 1 year, TRT patients demonstrated increased rates of ED utilization (26.6% vs. 16.9%, RR: 1.58, P < .001), acute kidney injury (17.5% vs. 12.1%, RR: 1.45, P < .001), and periprosthetic joint infection (PJI) (4.8% vs. 2.4%, RR: 2.00, P < .001). At 5 years, TRT was associated with increased rates of PJI (7.9% vs. 4.5%, RR: 1.74, P < .001).
CONCLUSIONS: Preoperative TRT is associated with an increased risk of PJI, acute kidney injury, and postoperative ED visits following TSA. These findings highlight the need for careful preoperative risk assessment and patient counseling when considering TSA in patients on TRT.